Latest Insider Transactions at Treace Medical Concepts, Inc. (TMCI)
This section provides a real-time view of insider transactions for Treace Medical Concepts, Inc. (TMCI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of TREACE MEDICAL CONCEPTS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of TREACE MEDICAL CONCEPTS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2024
|
Scot Michael Elder Chief Legl & Comp Off, CorpSec |
BUY
Grant, award, or other acquisition
|
Direct |
200,000
+31.35%
|
-
|
|
Sep 16
2024
|
John T. Treace Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+0.76%
|
$250,000
$5.31 P/Share
|
|
Sep 12
2024
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
33,750
+11.89%
|
$0
$0.1 P/Share
|
|
Aug 15
2024
|
James T Treace |
BUY
Open market or private purchase
|
Direct |
84,000
+6.42%
|
$420,000
$5.96 P/Share
|
|
Aug 14
2024
|
John T. Treace Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
85,000
+1.3%
|
$510,000
$6.0 P/Share
|
|
Aug 09
2024
|
Scot Michael Elder Chief Legl & Comp Off, CorpSec |
BUY
Grant, award, or other acquisition
|
Direct |
129,540
+35.25%
|
-
|
|
Aug 09
2024
|
Mark Hair Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
207,260
+36.03%
|
-
|
|
Aug 09
2024
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
120,900
+35.85%
|
-
|
|
Aug 09
2024
|
Aaron Berutti SVP, Sales |
BUY
Grant, award, or other acquisition
|
Direct |
60,450
+26.72%
|
-
|
|
Jun 11
2024
|
John T. Treace Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
45,000
+0.7%
|
$225,000
$5.88 P/Share
|
|
May 31
2024
|
James T Treace |
BUY
Open market or private purchase
|
Direct |
25,000
+2.15%
|
$150,000
$6.05 P/Share
|
|
May 29
2024
|
James T Treace |
BUY
Open market or private purchase
|
Direct |
25,000
+2.19%
|
$125,000
$5.2 P/Share
|
|
May 28
2024
|
James T Treace |
BUY
Open market or private purchase
|
Direct |
50,000
+4.39%
|
$250,000
$5.07 P/Share
|
|
May 24
2024
|
Richard W Mott |
BUY
Open market or private purchase
|
Direct |
18,000
+1.65%
|
$90,000
$5.19 P/Share
|
|
May 22
2024
|
Richard W Mott |
BUY
Open market or private purchase
|
Direct |
12,100
+1.13%
|
$48,400
$4.99 P/Share
|
|
May 21
2024
|
Lawrence W Hamilton |
BUY
Grant, award, or other acquisition
|
Direct |
15,091
+42.84%
|
-
|
|
May 21
2024
|
Betsy Hanna |
BUY
Grant, award, or other acquisition
|
Direct |
15,091
+41.44%
|
-
|
|
May 21
2024
|
Lance A Berry |
BUY
Grant, award, or other acquisition
|
Direct |
15,091
+42.19%
|
-
|
|
May 21
2024
|
John K Bakewell |
BUY
Grant, award, or other acquisition
|
Direct |
15,091
+9.13%
|
-
|
|
May 21
2024
|
Deepti Jain |
BUY
Grant, award, or other acquisition
|
Direct |
15,091
+24.57%
|
-
|
|
May 21
2024
|
Jane E Kiernan |
BUY
Grant, award, or other acquisition
|
Direct |
15,091
+27.38%
|
-
|
|
May 21
2024
|
Richard W Mott |
BUY
Grant, award, or other acquisition
|
Direct |
15,091
+1.43%
|
-
|
|
May 17
2024
|
John T. Treace Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
100,000
+1.55%
|
$500,000
$5.56 P/Share
|
|
May 14
2024
|
Jane E Kiernan |
BUY
Open market or private purchase
|
Direct |
19,356
+43.7%
|
$96,780
$5.17 P/Share
|
|
May 14
2024
|
John T. Treace Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
150,000
+2.35%
|
$750,000
$5.12 P/Share
|
|
May 13
2024
|
James T Treace |
BUY
Open market or private purchase
|
Direct |
145,000
+12.24%
|
$580,000
$4.54 P/Share
|
|
May 13
2024
|
Richard W Mott |
BUY
Open market or private purchase
|
Direct |
36,802
+3.46%
|
$147,208
$4.38 P/Share
|
|
May 13
2024
|
John T. Treace Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
150,000
+2.4%
|
$600,000
$4.56 P/Share
|
|
May 10
2024
|
Deepti Jain |
BUY
Open market or private purchase
|
Direct |
25,000
+44.46%
|
$100,000
$4.5 P/Share
|
|
May 10
2024
|
James T Treace |
BUY
Open market or private purchase
|
Direct |
83,000
+8.49%
|
$332,000
$4.53 P/Share
|
|
May 10
2024
|
Richard W Mott |
BUY
Open market or private purchase
|
Direct |
83,198
+7.75%
|
$332,792
$4.57 P/Share
|
|
May 10
2024
|
John K Bakewell |
BUY
Open market or private purchase
|
Direct |
130,000
+49.05%
|
$520,000
$4.57 P/Share
|
|
May 10
2024
|
John T. Treace Chief Executive Officer |
BUY
Open market or private purchase
|
Direct |
150,000
+2.46%
|
$600,000
$4.58 P/Share
|
|
Mar 10
2024
|
John T. Treace Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
5,021
-0.09%
|
-
|
|
Mar 10
2024
|
Mark Hair Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,088
-2.48%
|
-
|
|
Mar 10
2024
|
Aaron Berutti SVP, Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
1,815
-1.69%
|
-
|
|
Mar 10
2024
|
Scot Michael Elder Chief Legl & Comp Off, CorpSec |
SELL
Payment of exercise price or tax liability
|
Direct |
1,666
-1.51%
|
-
|
|
Mar 10
2024
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,396
-1.44%
|
-
|
|
Mar 08
2024
|
John T. Treace Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,064
-0.04%
|
-
|
|
Mar 08
2024
|
Mark Hair Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,067
-0.64%
|
-
|
|
Mar 08
2024
|
Aaron Berutti SVP, Sales |
SELL
Payment of exercise price or tax liability
|
Direct |
711
-0.66%
|
-
|
|
Mar 08
2024
|
Scot Michael Elder Chief Legl & Comp Off, CorpSec |
SELL
Payment of exercise price or tax liability
|
Direct |
169
-0.15%
|
-
|
|
Mar 08
2024
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
389
-0.4%
|
-
|
|
Jan 10
2024
|
Sean F. Scanlan Chief Innovation Officer |
BUY
Grant, award, or other acquisition
|
Direct |
65,025
+40.08%
|
-
|
|
Jan 10
2024
|
John T. Treace Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
178,325
+2.98%
|
-
|
|
Jan 10
2024
|
Mark Hair Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
92,875
+35.9%
|
-
|
|
Jan 10
2024
|
Scot Michael Elder Chief Legl & Comp Off, CorpSec |
BUY
Grant, award, or other acquisition
|
Direct |
61,300
+35.74%
|
-
|
|
Jan 10
2024
|
Aaron Berutti SVP, Sales |
BUY
Grant, award, or other acquisition
|
Direct |
65,025
+37.61%
|
-
|
|
Nov 02
2023
|
Sean F. Scanlan Chief Innovation Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
211
-0.65%
|
-
|
|
Nov 02
2023
|
Scot Michael Elder Chief Legl & Comp Off, CorpSec |
SELL
Payment of exercise price or tax liability
|
Direct |
609
-1.23%
|
-
|